Palisade Bio Inc expected to post a loss of 8 cents a share - Earnings Preview

Palisade Bio

11/11/2022 15:18

* Palisade Bio Inc  PALI.OQ   PALI.O  is expected to show no
change in quarterly revenue when it reports  results on November
14 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Palisade Bio Inc is
for a
loss of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $1.5​, above​ its last closing price of $0.08. ​​​

This summary was machine generated November 11 at 15:18 GMT. 
All figures in US dollars  unless otherwise stated